Division of an Iliac Crest Bone Biopsy Specimen to Allow Histomorphometry, Immunohistochemical, Molecular Analysis, and Tissue Banking: Technical Aspect and Applications.

BONE HISTOMORPHOMETRY ILIAC CREST BIOPSY METABOLIC BONE DISEASES MOLECULAR BIOLOGY TISSUE BANKING

Journal

JBMR plus
ISSN: 2473-4039
Titre abrégé: JBMR Plus
Pays: England
ID NLM: 101707013

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 17 06 2020
revised: 25 09 2020
accepted: 05 10 2020
entrez: 23 12 2020
pubmed: 24 12 2020
medline: 24 12 2020
Statut: epublish

Résumé

The evaluation of bone complications in chronic kidney disease (CKD) often requires a bone biopsy, the analysis of which can refine the diagnosis of bone defects. Bone histomorphometry performed on sections of the iliac crest biopsy remains the reference procedure for the quantitative assessment of bone health in CKD patients, whereas immunohistochemistry and other molecular biology analyses are indispensable tools for studying the disrupted signaling pathways. Traditionally, the whole iliac crest biopsy was included in methyl-methacrylate (MMA) and was exclusively used for bone histomorphometry to describe static, dynamic, and structural parameters. Therefore, further molecular analysis of the bone tissue or the need for tissue banking would require a second biopsy to be made, because inclusion in MMA prevents the extraction of good-quality nucleic acids. In this work, we describe a simple approach to divide a single iliac crest bone biopsy into multiple parts. This allows for simultaneous assessments of histology, immunohistochemistry, biomolecular analysis, and tissue banking while preserving the same bone surface area for histomorphometry. © 2020 American Society for Bone and Mineral Research © 2020 The Authors.

Identifiants

pubmed: 33354645
doi: 10.1002/jbm4.10424
pii: JBM410424
pmc: PMC7745880
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e10424

Informations de copyright

© 2020 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Références

J Bone Miner Res. 2013 Jan;28(1):2-17
pubmed: 23197339
J Bone Miner Metab. 2008;26(1):110-3
pubmed: 18095073
Ann Intern Med. 2018 Mar 20;168(6):422-430
pubmed: 29459980
J Nephrol. 2020 Jul 12;:
pubmed: 32656748
Bone. 2017 Jul;100:80-86
pubmed: 28119179
PLoS One. 2015 Mar 16;10(3):e0120856
pubmed: 25774916
J Bras Nefrol. 2018 Oct-Dec;40(4):366-374
pubmed: 30525179
Curr Opin Nephrol Hypertens. 2014 Jul;23(4):431-7
pubmed: 24867672
Clin Calcium. 2011 Apr;21(4):589-92
pubmed: 21447927
Indian J Hematol Blood Transfus. 2017 Dec;33(4):603-610
pubmed: 29075077
Curr Osteoporos Rep. 2017 Jun;15(3):178-186
pubmed: 28429254
JBMR Plus. 2020 Mar 25;4(5):e10353
pubmed: 32490328
Joint Bone Spine. 2012 Dec;79(6):544-9
pubmed: 23177912
Bone. 2020 Sep;138:115460
pubmed: 32485361
J Nephrol. 2017 Oct;30(5):645-652
pubmed: 28831679
Acta Reumatol Port. 2018 Jul-Sep;43(3):201-209
pubmed: 30414368
PLoS One. 2015 Sep 21;10(9):e0138156
pubmed: 26390291
Mol Aspects Med. 2006 Apr-Jun;27(2-3):126-39
pubmed: 16469371

Auteurs

Sylvain Picard (S)

Centre Hospitalier Universitaire (CHU) de Québec Research Center, L'Hôtel-Dieu de Québec Hospital, Endocrinology and Nephrology Axis, Faculty and Department of Medicine Université Laval Quebec City Quebec Canada.

Christian N Mayemba (CN)

Centre Hospitalier Universitaire (CHU) de Québec Research Center, L'Hôtel-Dieu de Québec Hospital, Endocrinology and Nephrology Axis, Faculty and Department of Medicine Université Laval Quebec City Quebec Canada.

Roth-Visal Ung (RV)

Centre Hospitalier Universitaire (CHU) de Québec Research Center, L'Hôtel-Dieu de Québec Hospital, Endocrinology and Nephrology Axis, Faculty and Department of Medicine Université Laval Quebec City Quebec Canada.

Simon Martel (S)

Centre Hospitalier Universitaire (CHU) de Québec Research Center, L'Hôtel-Dieu de Québec Hospital, Endocrinology and Nephrology Axis, Faculty and Department of Medicine Université Laval Quebec City Quebec Canada.

Fabrice Mac-Way (F)

Centre Hospitalier Universitaire (CHU) de Québec Research Center, L'Hôtel-Dieu de Québec Hospital, Endocrinology and Nephrology Axis, Faculty and Department of Medicine Université Laval Quebec City Quebec Canada.

Classifications MeSH